{"entities":{"Q9814":{"pageid":13975,"ns":120,"title":"Item:Q9814","lastrevid":205735,"modified":"2020-05-21T15:45:09Z","type":"item","id":"Q9814","labels":{"en":{"language":"en","value":"Nabhan C, et al. Leuk. Lymphoma (2004) cited as Ref 551 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9814$C0558166-0649-4F47-8E74-06F31B4B09D5","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9814$AB5A46D2-9865-4FDA-AA72-521604F44E3C","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"Nabhan C","type":"string"},"datatype":"string"},"type":"statement","id":"Q9814$66038387-E78A-4BB0-988D-8DB95E89C286","rank":"normal"}],"P138":[{"mainsnak":{"snaktype":"value","property":"P138","datavalue":{"value":"10.1080/10428190412331286096","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9814$05B93543-5732-485E-8A3D-48EAEECFD847","rank":"normal"}],"P140":[{"mainsnak":{"snaktype":"value","property":"P140","datavalue":{"value":"15512816","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9814$66969771-635A-4544-A7CC-6F9B24160E51","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2004-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9814$64A67BA0-D3FE-4B05-98BD-3BAA68800ACF","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"Leuk. Lymphoma","type":"string"},"datatype":"string"},"type":"statement","id":"Q9814$6A7C4F8A-A54C-42DF-A4D6-0A8C4DC73570","rank":"normal"}],"P103":[{"mainsnak":{"snaktype":"value","property":"P103","datavalue":{"value":"45","type":"string"},"datatype":"string"},"type":"statement","id":"Q9814$ECFDE449-F870-4201-9F27-28F0BFBEC95A","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"A pilot trial of rituximab and alemtuzumab combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL)","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9814$F7D01D5E-ED04-410F-88F1-18C128031C07","rank":"normal"}],"P105":[{"mainsnak":{"snaktype":"value","property":"P105","datavalue":{"value":"2269-2273","type":"string"},"datatype":"string"},"type":"statement","id":"Q9814$92F322D5-979E-4605-BCA7-2F40EE03C551","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"Nabhan C, et al. Leuk. Lymphoma (2004) cited as Ref 551 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/Nabhan_C,_et_al._Leuk._Lymphoma_(2004)_cited_as_Ref_551_in_DOI:_10.1038/s41392-020-0110-5"}}}}}